| |
| |
|
| Insider
Information: |
Hislop Colin |
| Relationship: |
Chief Medical Officer |
| City: |
Hayward |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
42,980 |
|
|
Indirect Shares
|
1,897 |
|
|
| Direct
Value |
$956 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
44,877 |
|
|
| Total
Value |
$956 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Anthera Pharmaceuticals Inc |
ANTH |
|
2015-11-13 |
19,147 |
2015-11-13 |
1,897 |
Premium* |
|
|
Aravive Inc |
ARAV |
Chief Medical Officer |
2017-10-19 |
23,833 |
2016-10-11 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ARAV |
Aravive Inc |
Chief Medical Officer |
• – – |
2017-10-19 |
4 |
S |
$2.55 |
$1,701 |
D/D |
(667) |
23,833 |
0 |
- |
|
| ARAV |
Aravive Inc |
Chief Medical Officer |
• – – |
2017-04-04 |
4 |
AS |
$21.20 |
$742,000 |
D/D |
(35,000) |
24,500 |
0 |
- |
|
| ARAV |
Aravive Inc |
Chief Medical Officer |
• – – |
2017-04-04 |
4 |
OE |
$8.17 |
$285,950 |
D/D |
35,000 |
59,500 |
0 |
- |
|
| ARAV |
Aravive Inc |
Chief Medical Officer |
• – – |
2017-01-27 |
4 |
A |
$0.00 |
$0 |
D/D |
19,500 |
24,500 |
0 |
- |
|
| ARAV |
Aravive Inc |
Chief Medical Officer |
• – – |
2016-10-11 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
Chief Medical Officer |
• – – |
2015-11-13 |
4 |
OE |
$1.61 |
$20,125 |
D/D |
12,500 |
31,647 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
Chief Medical Officer |
• – – |
2015-11-13 |
4 |
AS |
$5.31 |
$66,341 |
D/D |
(12,500) |
19,147 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
Chief Medical Officer |
• – – |
2015-11-11 |
4 |
S |
$5.38 |
$26,900 |
D/D |
(5,000) |
19,147 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
Chief Medical Officer |
• – – |
2014-03-25 |
4 |
A |
$0.00 |
$0 |
D/D |
3,864 |
24,147 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
Chief Medical Officer |
• – – |
2014-03-25 |
4 |
A |
$0.00 |
$0 |
D/D |
3,864 |
24,147 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
Chief Medical Officer |
• – – |
2014-03-25 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,323) |
20,283 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
Chief Medical Officer |
• – – |
2014-03-25 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,323) |
20,283 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
Chief Medical Officer |
• – – |
2013-03-25 |
4 |
A |
$0.00 |
$0 |
D/D |
59,132 |
144,091 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
Chief Medical Officer |
• – – |
2013-01-03 |
4 |
D |
$0.69 |
$3,146 |
D/D |
(4,560) |
84,959 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
Chief Medical Officer |
• – – |
2012-02-06 |
4 |
A |
$0.00 |
$0 |
D/D |
9,923 |
39,519 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
Chief Medical Officer |
• – – |
2012-02-03 |
4 |
AS |
$8.20 |
$246,000 |
D/D |
(30,000) |
27,967 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
Chief Medical Officer |
• – – |
2011-11-08 |
4 |
S |
$6.74 |
$101,163 |
D/D |
(15,000) |
57,967 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
Chief Medical Officer |
• – – |
2011-11-08 |
4 |
OE |
$0.26 |
$3,900 |
D/D |
15,000 |
72,967 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
Chief Medical Officer |
• – – |
2011-07-12 |
4 |
OE |
$0.26 |
$3,900 |
D/D |
15,000 |
57,967 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
Chief Medical Officer |
• – – |
2011-06-30 |
4 |
D |
$8.17 |
$142,975 |
D/D |
(17,500) |
42,967 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
Chief Medical Officer |
• – – |
2011-06-29 |
4 |
OE |
$0.26 |
$2,600 |
D/D |
10,000 |
60,062 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
Chief Medical Officer |
• – – |
2011-02-11 |
4 |
B |
$0.00 |
$0 |
D/D |
3,894 |
50,062 |
2.66 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
Sr. VP, Cardiovasc. Prod. |
• – – |
2010-09-21 |
4 |
OE |
$0.26 |
$3,818 |
I/I |
14,683 |
15,183 |
0 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
Sr. VP, Cardiovasc. Prod. |
• – – |
2010-08-18 |
4 |
B |
$4.80 |
$2,400 |
I/I |
500 |
500 |
1.91 |
- |
|
| ANTH |
Anthera Pharmaceuticals I... |
Sr. VP, Cardiovasc. Prod. |
• – – |
2010-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
45,841 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
